SEC Tracker
Get the app

Royalty Pharma RPRX

Royalty Pharma: signs a material agreement and discloses other events

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Signs a material agreement (1.01)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Royalty Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Teva Pharmaceutical Industries TEVA public float $18.2B, Jun 30, 2025
  2. Biogen BIIB public float $18.4B, Jun 30, 2025
  3. BeOne Medicines ONC public float $14.7B, Jun 30, 2025
  4. INSMED INSM public float $21.1B, Jun 30, 2025
  5. United Therapeutics UTHR public float $11.2B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.